The Preuss Foundation Monoclonal Antibody Research on Brain Tumors Seminar II
April 1-2, 1988
La Jolla, California
Darell D. Bigner, M.D., Ph.D. - Chairperson
Duke University Medical Center
Durham, North Carolina
Luther W. Brady, M.D.
Hahnemann University Hospital
Philadelphia, Pennsylvania
G. Yancey Gillespie, Ph.D.
University of Alabama, Birmingham
Birmingham, Alabama
Ingegerd Hellstrom, M.D.
Oncogen Company
Seattle, Washington
Dorothee Herlyn, D.V.M.
Wistar Institute
Philadelphia, Pennsylvania
Rakesh K. Jain, Ph.D.
Carnegie Mellon University
Pittsburgh, Pennsylvania
Steven M. Larson, M.D.
Memorial Sloan-Kettering Cancer Center
New York, New York
Clause Meares, Ph.D.
University of California, Davis
Davis, California
Joseph Moksal, Ph.D.
Montefiore Medical Center
Durham, North Carolina
Edward A. Neuwelt, M.D.
Oregon Health Sciences University
Portland, Oregon
Stanley E. Order, M.D.
Johns Hopkins University Oncology Center
Baltimore, Maryland
Roger J. Packer, M.D.
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania
Ralph A. Reisfeld, Ph.D.
Scripps Clinic and Research Foundation
La Jolla, CA
Mark Rosenblum, M.D.
University of California, San Francisco
San Francisco, California
Patrick J. Scannon, M.D., Ph.D.
XOMA Corporation
Berkeley, California
Martin Schrappe, M.D., Ph.D.
Scripps Clinic and Research Foundation
La Jolla, California
Peter Senter, Ph.D.
Oncogen Company
Seattle, Washington
Thomas A. Waltz, M.D.
Scripps Clinic and Research Foundation
La Jolla, California
Moody D. Wharam, M.D.
John Hopkins Oncology Center
Baltimore, Maryland
Carol J. Wilkstrand, Ph.D.
Duke University Medical Center
Bronx, New York
David V. Woo, Ph.D.
Hahnemann University Hospital
Philadelphia, Pennsylvania
Michael Zalutsky, Ph.D.
Duke University Medical Center
Durham, North Carolina